SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,137,242,000 | +15.0% | 11,660,432 | +9.4% | 9.46% | -6.3% |
| Q4 2014 | $989,182,000 | +34.9% | 10,660,432 | 0.0% | 10.10% | +9.3% |
| Q3 2014 | $733,225,000 | -34.4% | 10,660,432 | 0.0% | 9.23% | -32.5% |
| Q2 2014 | $1,117,213,000 | +26.5% | 10,660,432 | +0.1% | 13.68% | +21.9% |
| Q1 2014 | $883,480,000 | +32.9% | 10,648,182 | +3.7% | 11.23% | +19.8% |
| Q4 2013 | $664,880,000 | +2.1% | 10,273,182 | 0.0% | 9.37% | +1.2% |
| Q3 2013 | $651,238,000 | +68.2% | 10,273,182 | +11.4% | 9.26% | +20.9% |
| Q2 2013 | $387,189,000 | – | 9,223,182 | – | 7.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |